Insulin glargine and lixisenatide Subcutaneous and Sustiva (Efavirenz Capsules)
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Sustiva (Efavirenz Capsules) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: efavirenz
Brand name: Sustiva
Synonyms: Sustiva
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Sustiva (Efavirenz Tablets)
- Insulin glargine and lixisenatide Subcutaneous-Sustol
- Insulin glargine and lixisenatide Subcutaneous-Sustol injection
- Insulin glargine and lixisenatide Subcutaneous-SuTan
- Insulin glargine and lixisenatide Subcutaneous-SuTan-DM
- Insulin glargine and lixisenatide Subcutaneous-Sutent
- Sustiva (Efavirenz Capsules)-Insulin glargine, recombinant Subcutaneous
- Sustiva (Efavirenz Capsules)-Insulin glulisine
- Sustiva (Efavirenz Capsules)-Insulin Glulisine (Cartridges and Pens)
- Sustiva (Efavirenz Capsules)-Insulin Glulisine (Vials)
- Sustiva (Efavirenz Capsules)-Insulin glulisine Subcutaneous
- Sustiva (Efavirenz Capsules)-Insulin human inhaled Inhalation